Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China flag China · Delayed Price · Currency is CNY
15.74
+0.14 (0.90%)
Feb 3, 2026, 3:04 PM CST

SHE:002082 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
83.07158.73226.61467.62912.02574.18
Short-Term Investments
-11.15----
Cash & Short-Term Investments
83.07169.88226.61467.62912.02574.18
Cash Growth
-13.28%-25.04%-51.54%-48.73%58.84%-26.55%
Accounts Receivable
957.81,0381,1571,2631,1571,311
Other Receivables
51.5518.5758.6757.1520.5441
Receivables
1,0091,0561,2161,3201,1781,352
Inventory
248.92213.86255.91283.15261.41850.89
Prepaid Expenses
-5.583.314.464.13-
Other Current Assets
401.32357.81221.63125.34113.66305.29
Total Current Assets
1,7431,8031,9232,2012,4693,082
Property, Plant & Equipment
1,5381,5641,4951,2741,1751,739
Long-Term Investments
114.94112.0810.5212.3512.9115.3
Goodwill
127.96125.67125.46127.93194.79217.87
Other Intangible Assets
455.14461.79418.46430.97398.65491.68
Long-Term Accounts Receivable
14.7114.0612.796.573.975.88
Long-Term Deferred Tax Assets
150.62134.44113.6290.5454.2347.02
Long-Term Deferred Charges
79.4363.0458.530.223.5219.89
Other Long-Term Assets
318.8448.91138.6944.4739.0644
Total Assets
4,5424,3274,2964,2184,3715,662
Accounts Payable
287.83247.36302.55231.18254.51355.61
Accrued Expenses
21.2267.3373.0863.7995.99132.8
Short-Term Debt
692.65855.17825.43677.96572.211,116
Current Portion of Long-Term Debt
55.8154.1954.2737.2831.512.11
Current Portion of Leases
-3.242.650.550.54-
Current Income Taxes Payable
34.418.1317.3424.6190.2549.29
Current Unearned Revenue
7.116.8214.3130.2833.2175.65
Other Current Liabilities
88.4654.0236.9871.61105.19123.33
Total Current Liabilities
1,1871,3161,3271,1371,2831,865
Long-Term Debt
153.4310481.51135.2237746.8
Long-Term Leases
13.2311.6111.9913.431.22-
Long-Term Unearned Revenue
88.3892.1870.5468.0659.37102.52
Long-Term Deferred Tax Liabilities
45.0144.2140.8339.3633.531.07
Other Long-Term Liabilities
287.892.685.916.4812.1958.75
Total Liabilities
1,7751,5711,5371,4001,6272,804
Common Stock
611.69616.69616.69618.22618.22618.22
Additional Paid-In Capital
256.79311.78311.78305.79305.79320.08
Retained Earnings
1,8311,8271,8201,8441,7511,708
Treasury Stock
--59.99-59.99-59.99-50.96-
Comprehensive Income & Other
-24.82-28.34-30.92-21-25.88-24.21
Total Common Equity
2,6752,6672,6582,6872,5982,622
Minority Interest
91.6889.64101.28131.02146.33236.47
Shareholders' Equity
2,7672,7562,7592,8182,7452,858
Total Liabilities & Equity
4,5424,3274,2964,2184,3715,662
Total Debt
915.121,028975.84864.42842.481,875
Net Cash (Debt)
-832.05-858.34-749.23-396.869.54-1,301
Net Cash Per Share
-1.70-1.39-1.22-0.640.11-2.15
Filing Date Shares Outstanding
611.69611.69611.69613.22614.08618.22
Total Common Shares Outstanding
611.69611.69611.69613.22614.08618.22
Working Capital
555.22487.05596.661,0641,1851,217
Book Value Per Share
4.374.364.344.384.234.24
Tangible Book Value
2,0922,0792,1142,1282,0051,912
Tangible Book Value Per Share
3.423.403.463.473.263.09
Buildings
-893.08700.33577.02530.22381.11
Machinery
-777.07703.7679.8668.651,226
Construction In Progress
-510.85611.33472.39380.881,043
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.